Close

Provectus Biopharma (PVCT) Announces Receipt of U.S. Patent Related to PV-10 Manufacturing Process

March 1, 2016 9:28 AM EST Send to a Friend
Provectus Biopharmaceuticals, Inc. (NYSE: PVCT,) announced that it has received a patent from the U.S. Patent and Trademark Office, U.S ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login